These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8710007)

  • 1. [Long-term complications in diabetes mellitus: role of irreversible glycosylation products].
    Treskes M; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1996 Jun; 140(25):1299-303. PubMed ID: 8710007
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.
    Vlassara H; Bucala R; Striker L
    Lab Invest; 1994 Feb; 70(2):138-51. PubMed ID: 8139257
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes and advanced glycoxidation end products.
    Huebschmann AG; Regensteiner JG; Vlassara H; Reusch JE
    Diabetes Care; 2006 Jun; 29(6):1420-32. PubMed ID: 16732039
    [No Abstract]   [Full Text] [Related]  

  • 4. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
    Rojas A; Morales MA
    Life Sci; 2004 Dec; 76(7):715-30. PubMed ID: 15581904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accumulation of AGE (advanced glycosylation end-products) in the aging process, in diabetes mellitus and in chronic renal failure].
    Wisotzky J; Sommer M; Schubert K; Stein G
    Med Klin (Munich); 1996 Jul; 91(7):454-7. PubMed ID: 8756114
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy.
    Chiarelli F; Mansour M; Verrotti A
    Diabetes Nutr Metab; 2000 Aug; 13(4):192-9. PubMed ID: 10961486
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycated proteins in diabetes.
    Furth AJ
    Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.
    Kalousová M; Zima T; Tesar V; Dusilová-Sulková S; Skrha J
    Mutat Res; 2005 Nov; 579(1-2):37-46. PubMed ID: 16084533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of advanced glycosylation end products in the pathogenesis of hypertension].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2003; 60(9):585-7. PubMed ID: 15065338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
    Ramasamy R; Yan SF; Schmidt AM
    Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advanced glycosylation end products or glycotoxins: under-evaluated components of diet?].
    Wautier JL
    Rev Prat; 2001 Sep; 51(13):1397-9. PubMed ID: 11601066
    [No Abstract]   [Full Text] [Related]  

  • 13. Methylglyoxal: possible link between hyperglycaemia and immune suppression?
    Price CL; Knight SC
    Trends Endocrinol Metab; 2009 Sep; 20(7):312-7. PubMed ID: 19709901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AGE/RAGE axis in diabetes-accelerated atherosclerosis.
    Jandeleit-Dahm K; Watson A; Soro-Paavonen A
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):329-34. PubMed ID: 18290873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.
    Yan SF; Ramasamy R; Naka Y; Schmidt AM
    Circ Res; 2003 Dec; 93(12):1159-69. PubMed ID: 14670831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus.
    Yoon MS; Jankowski V; Montag S; Zidek W; Henning L; Schlüter H; Tepel M; Jankowski J
    Biochem Biophys Res Commun; 2004 Oct; 323(2):377-81. PubMed ID: 15369762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of advanced glycation end-products in the development of atherosclerosis.
    Odetti P
    Ital Heart J; 2001 Sep; 2 Suppl 3():34S-36S. PubMed ID: 11593929
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF; Yan SD; Herold K; Ramsamy R; Schmidt AM
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):511-24, viii. PubMed ID: 16959583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
    Yan SF; Ramasamy R; Schmidt AM
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.